INV-2821

N/A

Report date: 2025/07/09 11:08:19
NME

Base Information

Drug NameINV-2821
Drug Alias NameINV-2821
ClassificationOther
Mechanisms of ActionCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Ionova Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Ionova Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A